Clayton Financial Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
ATO
QP
Clayton Financial Group's MRK Position: Q2 2026 in Review
Clayton Financial Group sold out of Merck (MRK) in Q2 2026, closing a stake of 675 shares — an estimated $81.2K sold.
Clayton Financial Group first reported a position in MRK in Q1 2024 and held it in 7 quarters. The position peaked at $707K in Q2 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Clayton Financial Group reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Clayton Financial Group sold 675 Merck shares in Q2 2026, an estimated $81.2K.
- Clayton Financial Group first reported a position in Merck in Q1 2024 and held it in 7 quarters.
- Clayton Financial Group's Merck position peaked at $707K in Q2 2024.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.